GRIM-1, a novel growth suppressor, inhibits rRNA maturation by suppressing small nucleolar RNAs

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Nallar, Shreeram C ^a   Lin, Limei ^a   Srivastava, Varsha ^a   Gade, Padmaja ^a   Hofmann, Edward R ^a   Ahmed, Hafiz ^a   Reddy, Sekhar P ^b   Kalvakolanu, Dhananjaya V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSKERIN; MESSENGER RNA; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; SMALL NUCLEOLAR RNA; APOPTOSIS REGULATORY PROTEIN; BETA INTERFERON; CELL CYCLE PROTEIN; DKC1 PROTEIN, HUMAN; ISOPROTEIN; NAF1 PROTEIN, HUMAN; NUCLEAR PROTEIN; RETINOIC ACID; RIBONUCLEOPROTEIN; RIBOSOME RNA; SACCHAROMYCES CEREVISIAE PROTEIN; SHQ1 PROTEIN, S CEREVISIAE; SMALL UNTRANSLATED RNA;

APOPTOSIS; ARTICLE; BIOGENESIS; CARBOXY TERMINAL SEQUENCE; CELL DEATH; COILED BODY; CONTROLLED STUDY; DEPLETION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE ISOLATION; GENE STRUCTURE; GENETIC ASSOCIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RETINOID INTERFERON INDUCED MORTALITY 1 GENE; RNA GENE; RNA INTERFERENCE; CELL GROWTH; DRUG EFFECT; GENETICS; HELA CELL; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOPLASM; PATHOLOGY; PROSTATE TUMOR; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

MAMMALIA;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-BETA; MALE; NEOPLASMS; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOPROTEINS; RNA, RIBOSOMAL; RNA, SMALL NUCLEOLAR; RNA, SMALL UNTRANSLATED; SACCHAROMYCES CEREVISIAE PROTEINS; TRETINOIN;

EID: 80052544239     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024082     Document Type: Article

References (61)

1. Kalvakolanu DV, (2004) The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression. Cytokine Growth Factor Rev 15: 169-194.
2. Dunn GP, Koebel CM, Schreiber RD, (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6: 836-848.
3. Zhou A, Hassel BA, Silverman RH, (1993) Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72: 753-765.
4. Guo J, Hui DJ, Merrick WC, Sen GC, (2000) A new pathway of translational regulation mediated by eukaryotic initiation factor 3. Embo J 19: 6891-6899.
5. Kroczynska B, Kaur S, Platanias LC, (2009) Growth suppressive cytokines and the AKT/mTOR pathway. Cytokine 48: 138-143.
6. Angell JE, Lindner DJ, Shapiro PS, Hofmann ER, Kalvakolanu DV, (2000) Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem 275: 33416-33426.
7. Hofmann ER, Boyanapalli M, Lindner DJ, Weihua X, Hassel BA, et al. (1998) Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid. Mol Cell Biol 18: 6493-6504.
8. Hofmann ER, Nallar SC, Lin L, D'Cunha J, Lindner DJ, et al. (2010) Identification and characterization of GRIM-1, a cell-death-associated gene product. J Cell Sci 123: 2781-2791.
9. Belin S, Beghin A, Solano-Gonzalez E, Bezin L, Brunet-Manquat S, et al. (2009) Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS One 4: e7147.
10. Silvera D, Formenti SC, Schneider RJ, (2010) Translational control in cancer. Nat Rev Cancer 10: 254-266.
11. Ohene-Abuakwa Y, Orfali KA, Marius C, Ball SE, (2005) Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect. Blood 105: 838-846.
12. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, et al. (2003) Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299: 259-262.
13. Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, et al. (2005) c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 7: 303-310.
14. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, et al. (2005) c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 7: 311-318.
15. Trere D, Ceccarelli C, Montanaro L, Tosti E, Derenzini M, (2004) Nucleolar size and activity are related to pRb and p53 status in human breast cancer. J Histochem Cytochem 52: 1601-1607.
16. Ding L, Ellis MJ, Li S, Larson DE, Chen K, et al. (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999-1005.
17. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18: 11-22.
18. Yang PK, Rotondo G, Porras T, Legrain P, Chanfreau G, (2002) The Shq1p.Naf1p complex is required for box H/ACA small nucleolar ribonucleoprotein particle biogenesis. J Biol Chem 277: 45235-45242.
19. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, et al. (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci U S A 98: 4569-4574.
20. Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, et al. (2002) Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415: 180-183.
21. Darzacq X, Kittur N, Roy S, Shav-Tal Y, Singer RH, et al. (2006) Stepwise RNP assembly at the site of H/ACA RNA transcription in human cells. J Cell Biol 173: 207-218.
22. Hoareau-Aveilla C, Bonoli M, Caizergues-Ferrer M, Henry Y, (2006) hNaf1 is required for accumulation of human box H/ACA snoRNPs, scaRNPs, and telomerase. Rna 12: 832-840.
23. Kittur N, Darzacq X, Roy S, Singer RH, Meier UT, (2006) Dynamic association and localization of human H/ACA RNP proteins. Rna 12: 2057-2062.
24. Sun P, Nallar SC, Kalakonda S, Lindner DJ, Martin SS, et al. (2009) GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring. Oncogene 28: 1339-1347.
25. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, et al. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112.
26. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, et al. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21: 635-637.
27. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, et al. (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 101: 1892-1897.
28. Grozdanov PN, Roy S, Kittur N, Meier UT, (2009) SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs. Rna 15: 1188-1197.
29. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD, (1998) How cells respond to interferons. Annu Rev Biochem 67: 227-264.
30. Clemens MJ, Elia A, (1997) The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17: 503-524.
31. Thomis DC, Doohan JP, Samuel CE, (1992) Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells. Virology 188: 33-46.
32. Gale M Jr, Tan SL, Katze MG, (2000) Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev 64: 239-280.
33. Player MR, Torrence PF, (1998) The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol Ther 78: 55-113.
34. Rebouillat D, Hovanessian AG, (1999) The human 2′, 5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res 19: 295-308.
35. Li XL, Blackford JA, Judge CS, Liu M, Xiao W, et al. (2000) RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J Biol Chem 275: 8880-8888.
36. Gongora C, David G, Pintard L, Tissot C, Hua TD, et al. (1997) Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J Biol Chem 272: 19457-19463.
37. Singh M, Gonzales FA, Cascio D, Heckmann N, Chanfreau G, et al. (2009) Structure and functional studies of the CS domain of the essential H/ACA ribonucleoparticle assembly protein SHQ1. J Biol Chem 284: 1906-1916.
38. Leulliot N, Godin KS, Hoareau-Aveilla C, Quevillon-Cheruel S, Varani G, et al. (2007) The box H/ACA RNP assembly factor Naf1p contains a domain homologous to Gar1p mediating its interaction with Cbf5p. J Mol Biol 371: 1338-1353.
39. Ge J, Rudnick DA, He J, Crimmins DL, Ladenson JH, et al. (2010) Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Mol Cell Biol 30: 413-422.
40. Campisi J, (2002) Cancer and aging: yin, yang, and p53. Sci Aging Knowledge Environ 2002: pe1.
41. Deppert W, (1994) The yin and yang of p53 in cellular proliferation. Semin Cancer Biol 5: 187-202.
42. Weston CR, Davis RJ, (2007) The JNK signal transduction pathway. Curr Opin Cell Biol 19: 142-149.
43. Dez C, Noaillac-Depeyre J, Caizergues-Ferrer M, Henry Y, (2002) Naf1p, an essential nucleoplasmic factor specifically required for accumulation of box H/ACA small nucleolar RNPs. Mol Cell Biol 22: 7053-7065.
44. Trahan C, Martel C, Dragon F, (2010) Effects of dyskeratosis congenita mutations in dyskerin, NHP2 and NOP10 on assembly of H/ACA pre-RNPs. Hum Mol Genet 19: 825-836.
45. Grozdanov PN, Fernandez-Fuentes N, Fiser A, Meier UT, (2009) Pathogenic NAP57 mutations decrease ribonucleoprotein assembly in dyskeratosis congenita. Hum Mol Genet 18: 4546-4551.
46. Ganot P, Bortolin ML, Kiss T, (1997) Site-specific pseudouridine formation in preribosomal RNA is guided by small nucleolar RNAs. Cell 89: 799-809.
47. Ni J, Tien AL, Fournier MJ, (1997) Small nucleolar RNAs direct site-specific synthesis of pseudouridine in ribosomal RNA. Cell 89: 565-573.
48. Cavaille J, Nicoloso M, Bachellerie JP, (1996) Targeted ribose methylation of RNA in vivo directed by tailored antisense RNA guides. Nature 383: 732-735.
49. Kiss-Laszlo Z, Henry Y, Bachellerie JP, Caizergues-Ferrer M, Kiss T, (1996) Site-specific ribose methylation of preribosomal RNA: a novel function for small nucleolar RNAs. Cell 85: 1077-1088.
50. Castle JC, Armour CD, Lower M, Haynor D, Biery M, et al. (2010) Digital genome-wide ncRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification. PLoS One 5: e11779.
51. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, et al. (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 19: 32-38.
52. Walne AJ, Vulliamy T, Marrone A, Beswick R, Kirwan M, et al. (2007) Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet 16: 1619-1629.
53. Vulliamy T, Beswick R, Kirwan M, Marrone A, Digweed M, et al. (2008) Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A 105: 8073-8078.
54. Dokal I, (2001) Dyskeratosis congenita. A disease of premature ageing. Lancet 358 (Suppl): S27.
55. Yoon A, Peng G, Brandenburger Y, Zollo O, Xu W, et al. (2006) Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 312: 902-906.
56. Schippert R, Schaeffel F, Feldkaemper MP, (2008) Microarray analysis of retinal gene expression in chicks during imposed myopic defocus. Mol Vis 14: 1589-1599.
57. Amsterdam A, Sadler KC, Lai K, Farrington S, Bronson RT, et al. (2004) Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2: E139.
58. Ender C, Krek A, Friedlander MR, Beitzinger M, Weinmann L, et al. (2008) A human snoRNA with microRNA-like functions. Mol Cell 32: 519-528.
59. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, et al. (2011) The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis. Br J Cancer 104: 1168-1177.
60. Killian A, Le Meur N, Sesboue R, Bourguignon J, Bougeard G, et al. (2004) Inactivation of the RRB1-Pescadillo pathway involved in ribosome biogenesis induces chromosomal instability. Oncogene 23: 8597-8602.
61. Jiang H, Lin JJ, Tao J, Fisher PB, (1997) Suppression of human ribosomal protein L23A expression during cell growth inhibition by interferon-beta. Oncogene 14: 473-480.